ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma

Hsieh, Celina; Laguna, Amanda; Ikeda, Ian; Maxwell, Aaron W. P.; Chapiro, Julius; Nadolski, Gregory; Jiao, Zhicheng; Bai, Harrison X.*
RADIOLOGY2023-11DOI: 10.1148/radiol.222891
7被引8阅读
引用收藏
分享

摘要

Interventional oncology is a rapidly growing field with advances in minimally invasive image-guided local-regional treatments for hepatocellular carcinoma (HCC), including transarterial chemoembolization, transarterial radioembolization, and thermal ablation. However, current standardized clinical staging systems for HCC are limited in their ability to optimize patient selection for treatment as they rely primarily on serum markers and radiologist-defined imaging features. Given the variation in treatment responses, an updated scoring system that includes multidimensional aspects of the disease, including quantitative imaging features, serum markers, and functional biomarkers, is needed to optimally triage patients. With the vast amounts of numerical medical record data and imaging features, researchers have turned to image-based methods, such as radiomics and artificial intelligence (AI), to automatically extract and process multidimensional data from images. The synthesis of these data can provide clinically relevant results to guide personalized treatment plans and optimize resource utilization. Machine learning (ML) is a branch of AI in which a model learns from training data and makes effective predictions by teaching itself. This review article outlines the basics of ML and provides a comprehensive overview of its potential value in the prediction of treatment response in patients with HCC after minimally invasive image-guided therapy.

学科与关键词

关键词
TRANSARTERIAL CHEMOEMBOLIZATIONARTIFICIAL-INTELLIGENCERADIOMICSEMBOLIZATIONVALIDATIONRECURRENCESYSTEMSCORE
相关
加载中…
  • Current Status and Analysis of Machine Learning in Hepatocellular Carcinoma
    Feng, Sijia; Wang, Jianhua; Wang, Liheng; Qiu, Qixuan; Chen, Dongdong; Su, Huo; Li, Xiaoli; Xiao, Yao; Lin, Chiayen*Journal of Clinical and Translational Hepatology, 2023, 11(5): 1184-1191.被引 16
  • An interpretable machine learning model based on contrast-enhanced CT parameters for predicting treatment response to conventional transarterial chemoembolization in patients with hepatocellular carcinoma
    Zhang, Lu; Jin, Zhe; Li, Chen; He, Zicong; Zhang, Bin; Chen, Qiuying; You, Jingjing; Ma, Xiao; Shen, Hui; Wang, Fei; Wu, Lingeng*; Ma, Cunwen*; Zhang, Shuixing*Radiologia Medica, 2024.
  • Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep Learning
    Peng, Jie*; Huang, Jinhua*; Huang, Guijia; Zhang, JingFrontiers in Oncology, 2021, 11: 730282.被引 16
查看全部 →

发表信息

论文状态
公开发表
期刊
RADIOLOGY
发表日期
2023-11
卷期
第 309 卷, 第 2 期
页码
e222891
DOI
10.1148/radiol.222891
语言
ENGLISH
成果收录
SCIE

作者

  • H

    Hsieh, Celina (第一作者)

  • L

    Laguna, Amanda

查看全部 8 位作者收起作者
  • I

    Ikeda, Ian

  • M

    Maxwell, Aaron W. P.

  • C

    Chapiro, Julius

  • N

    Nadolski, Gregory

  • J

    Jiao, Zhicheng

  • B

    Bai, Harrison X. (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417